WebAris Kekedjian joined the Board of Trinity Biotech in May 2024 and became CEO in October 2024. Mr. Kekedjian spent 30 years in GE in several senior roles, including as GE’s Chief Investment Officer and Global Head of Business Development. WebChairman Aris Kekedjian joined the Board of Trinity Biotech in May 2024 and became CEO in October 2024. Mr. Kekedjian spent 30 years in GE in several senior roles, including as GE’s Chief Investment Officer and Global Head of Business Development. Mr.
Billionaire investor Carl Icahn taps Aris Kekedjian as …
Web23 mar 2024 · Trinity Biotech plc (NasdaqGS:TRIB) ha dichiarato che sta conducendo una revisione del portafoglio di tutte le attività che non si allineano con il suo focus strategico intorno a tre priorità chiave, in particolare: Diabete/Emoglobine; Point of Care & Digital Health Disruption; Monitoraggio terapeutico personalizzato dei farmaci. Web4 apr 2024 · Kekedjian, a 30-year GE veteran, ran the conglomerate’s businesses in Europe and the Middle East. He was GE’s chief investment officer until 2024. Since then, … gho period medicare
Icahn Taps Ex-GE M&A Chief Kekedjian to Lead Firm
Web27 gen 2024 · Mr. Kekedjian brings a wealth of global leadership and strategic transformation experience to this timely discussion, having previously served as Head of … Web31 ago 2015 · Aris Kekedjian, head dealmaker for GE's lending arm, was hours away from an April deadline to sell $US23 billion in real estate assets – the centrepiece of a plan to jettison virtually all of its... Web27 gen 2024 · January 27, 2024 - 11:31 am. MENLO PARK, Calif. TCC, an innovator in the supply chain finance ecosystem, today announced it is hosting former Icahn Enterprises CEO Aris Kekedjian, and renowned professor of economics at Stanford University Dr. Yossi Feinberg at a panel on key strategies to weather the recession many analysts are … gho pharma